CRSP: CRISPR Therapeutics AG Quarterly Revenue Growth

CRSP (CRISPR Therapeutics AG) - company brandmark

CRISPR Therapeutics AG (CRSP) is a leader in genetic engineering that developed the commercial drug Casgevy based on unique patents. Manufacturing capacities are expanding through the validation of contract sites. The current quarterly revenue growth rate illustrates the business expansion dynamics, where 1327.90 captures the current value of the indicator. Ownership of "molecular scissors" technology allows the company to effectively treat severe hereditary pathologies, confirming the safety of the method.

CRSP CRISPR Therapeutics Inc Revenue Dynamics QoQ (07/04/2022 - 11/21/2026)

Summary analytical data breakdowns for CRISPR Therapeutics Corp (CRSP)

- current quotes and average value forecast:
Summary company analytics:crisprtx.com (CRSP)
Flagship merchandise of CRISPR Therapeutics Inc

This metric measures the percentage change in revenue between the current and previous quarter, capturing the business scaling speed and the efficiency of product commercialization. For the non-cyclical gene editing sector of CRISPR Therapeutics (CRSP), which remains independent of GDP, this quarterly revenue trend serves as the primary indicator of the transition from clinical development to actual sales, eliminating the impact of seasonal fluctuations.

Competitors of CRISPR Therapeutics AG

TEM - Revenue Growth QoQ|Quarterly Sales Growth Rate qiagen.com QGEN|IONS: Quarterly Revenue Growth|Repligen Corp - Quarterly Revenue Increase|RNA (Avidity Corp) - Quarterly Revenue Growth|WGS - Revenue Change vs Previous Quarter|Quarterly Revenue Growth RARE|Sales Change QoQ BEAM|Quarterly Revenue Growth SRPT (Sarepta Corp)|TWST - Quarterly Sales Growth|TXG: Quarterly Sales Growth|Quarterly Revenue Growth Rate Intellia Therapeutics|STOK: Quarterly Revenue Growth|BLFS - Quarterly Sales Growth Rate|Quarterly Sales Growth WVE|MAZE: Quarterly Revenue Increase|Revenue Growth QoQ Sionna Corp (SION)|Quarterly Sales Growth Rate Prime Medicine Bio|Quarterly Revenue Growth TSHA (Taysha Gene Therapies Inc)|Quarterly Revenue Growth uniqure.com QURE|MeiraGTx Holdings - Quarterly Revenue Growth|RGNX - Quarterly Revenue Growth|SLDB (Solid Corp) - Quarterly Sales Growth|Revenue Change vs Previous Quarter Ocugen Corp OCGN|PACB (Pacific Biosciences) - Quarterly Revenue Growth|Revenue Growth QoQ BNTC|Quarterly Revenue Growth DSGN|Quarterly Sales Growth Rocket Pharma RCKT|Quarterly Sales Growth Rate FDMT|Quarterly Revenue Growth Lexeo Therapeutics LXEO|KRRO - Revenue Growth QoQ|EDIT (Editas Medicine, Inc.) - Sales Growth QoQ|SLN: Quarterly Revenue Growth|ProQR - Quarterly Revenue Increase|CDXS (Codexis) - Quarterly Revenue Growth|Sangamo (SGMO) - Quarterly Sales Growth Rate|Quarterly Revenue Growth NAUT|Quarterly Sales Growth Metagenomi, Inc. MGX|Revenue Growth QoQ Precision BioSciences DTIL|Quarterly Revenue Increase GBIO|BOLD - Revenue Growth QoQ|Quarterly Sales Growth Rate Exicure Inc. XCUR|Imunon, Inc. (IMNN) - Revenue Growth QoQ|RXi Pharmaceuticals - Quarterly Revenue Increase|MBIO (Mustang Bio) - Quarterly Revenue Growth|Sales Growth QoQ RNAZ (transcodetherapeutics.com)|Revenue Growth QoQ Bionano (BNGO)|Applied DNA Sciences - Sales Growth QoQ|Quarterly Revenue Growth BLUE (bluebirdbio.com)|ImmunoPrecise Antibodies (IPA) - Quarterly Revenue Growth Rate|omegatherapeutics.com - Quarterly Revenue Growth|Revenue Change vs Previous Quarter Singular Genomics Systems Inc (OMIC)|RGLS: Quarterly Revenue Growth|Syros Pharmaceuticals, Inc (SYRS) - Quarterly Revenue Growth|TBIO (telesisbio.com) - Quarterly Revenue Growth|TCON: Quarterly Revenue Increase|Revenue Growth QoQ Unity Biotechnology, Inc (UBX)